Cargando…

Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications

Obesity is a triggering factor for diabetes associated with insulin resistance. In individuals who are obese, higher amounts of non-esterified fatty acids, glycerol, hormones, and pro-inflammatory cytokines that could participate in the development of insulin resistance are released by adipose tissu...

Descripción completa

Detalles Bibliográficos
Autor principal:	Wondmkun, Yohannes Tsegyie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553667/ https://www.ncbi.nlm.nih.gov/pubmed/33116712 http://dx.doi.org/10.2147/DMSO.S275898

Ejemplares similares

A Review on Novel Drug Targets and Future Directions for COVID-19 Treatment
por: Wondmkun, Yohannes Tsegyie, et al.
Publicado: (2020)

Assessment of Prescription Pattern of Systemic Steroidal Drugs in the Outpatient Department of Menelik II Referral Hospital, Addis Ababa, Ethiopia, 2019
por: Wondmkun, Yohannes Tsegyie, et al.
Publicado: (2021)

Evaluations of the in vivo laxative effects of aqueous root extracts of Euclea racemosa L. in mice
por: Ayele, Akeberegn Gorems, et al.
Publicado: (2022)

Wound Healing Activity of 80% Methanol Leaf Extract of Zehneria scabra (L.f) Sond (Cucurbitaceae) in Mice
por: Tekleyes, Bezu, et al.
Publicado: (2021)

Chemopreventive Activity of 80% Methanol Leaf Extract of Vernonia auriculifera Hiern (Asteraceae) Against Dimethylhydrazine-Induced Colorectal Carcinogenesis in Rats
por: Wondmkun, Yohannes Tsegyie, et al.
Publicado: (2023)

The involvement of aldosterone on vascular insulin resistance: implications in obesity and type 2 diabetes
por: Bruder-Nascimento, Thiago, et al.
Publicado: (2014)

Diabetes, obesity, and insulin resistance in COVID-19: molecular interrelationship and therapeutic implications
por: Santos, Andrey, et al.
Publicado: (2021)

Zinc transporters and insulin resistance: therapeutic implications for type 2 diabetes and metabolic disease
por: Norouzi, Shaghayegh, et al.
Publicado: (2017)

Molecular Mechanism of Insulin Resistance in Obesity and Type 2 Diabetes
por: Choi, Kangduk, et al.
Publicado: (2010)

Complement activation in obesity, insulin resistance, and type 2 diabetes mellitus
por: Shim, Kyumin, et al.
Publicado: (2020)

The Insulin-Like Growth Factor System in Obesity, Insulin Resistance and Type 2 Diabetes Mellitus
por: Lewitt, Moira S., et al.
Publicado: (2014)

Seafood intake and the development of obesity, insulin resistance and type 2 diabetes
por: Liaset, Bjørn, et al.
Publicado: (2019)

Insulin Clearance in Obesity and Type 2 Diabetes
por: Koh, Han-Chow E., et al.
Publicado: (2022)

Type 2 Diabetes Mellitus and Alzheimer’s Disease: Role of Insulin Signalling and Therapeutic Implications
por: Tumminia, Andrea, et al.
Publicado: (2018)

Management of obesity, insulin resistance and type 2 diabetes in children: consensus and controversy
por: Fleischman, Amy, et al.
Publicado: (2009)

Metabolic signature of obesity-associated insulin resistance and type 2 diabetes
por: Al-Sulaiti, Haya, et al.
Publicado: (2019)

Obesity, insulin resistance, and the pathway to type 2 diabetes
por: Bergman, Richard N
Publicado: (2012)

Role of skeletal muscle lipids in the pathogenesis of insulin resistance of obesity and type 2 diabetes
por: Gilbert, Marc
Publicado: (2021)

Insulin detemir for the treatment of obese patients with type 2 diabetes
por: Hollander, Priscilla A
Publicado: (2012)

Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences
por: Hong, So-hyeon, et al.
Publicado: (2020)

Rewiring of Lipid Metabolism in Adipose Tissue Macrophages in Obesity: Impact on Insulin Resistance and Type 2 Diabetes
por: Dahik, Veronica D., et al.
Publicado: (2020)

Insulin resistance and type 2 diabetes in children
por: Castorani, Valeria, et al.
Publicado: (2020)

Major Pathophysiology in Prediabetes and Type 2 Diabetes: Decreased Insulin in Lean and Insulin Resistance in Obese
por: Kabadi, Udaya M.
Publicado: (2017)

Potential Role of Insulin Growth-Factor-Binding Protein 2 as Therapeutic Target for Obesity-Related Insulin Resistance
por: Boughanem, Hatim, et al.
Publicado: (2021)

Implications of Resveratrol in Obesity and Insulin Resistance: A State-of-the-Art Review
por: Barber, Thomas M., et al.
Publicado: (2022)

Topics in Type 2 Diabetes and Insulin Resistance
por: Bloomgarden, Zachary T.
Publicado: (2009)

Implications of publicly available genomic data resources in searching for therapeutic targets of obesity and type 2 diabetes
por: Jung, Sungwon
Publicado: (2018)

The Intriguing Intersection of Type 2 Diabetes, Obesity-Related Insulin Resistance, and Osteoarthritis
por: Bradley, David
Publicado: (2021)

Incidence of Insulin Resistance in Obese Adolescent of Type-2 Diabetes Mellitus Patients
por: Javaid, Farrukh, et al.
Publicado: (2021)

NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2
por: Marušić, Marinko, et al.
Publicado: (2021)

Association of obesity and insulin resistance to gestational diabetes mellitus
por: Thilak, Swathi, et al.
Publicado: (2023)

Role of obesity-induced inflammation in the development of insulin resistance and type 2 diabetes: history of the research and remaining questions
por: Kim, Jieun, et al.
Publicado: (2021)

β-Cell Expansion for Therapeutic Compensation of Insulin Resistance in Type 2 Diabetes
por: Efrat, Shimon
Publicado: (2003)

Effect of Inulin-Type Carbohydrates on Insulin Resistance in Patients with Type 2 Diabetes and Obesity: A Systematic Review and Meta-Analysis
por: Rao, Mingyue, et al.
Publicado: (2019)

Higher Levels of ANGPTL5 in the Circulation of Subjects With Obesity and Type 2 Diabetes Are Associated With Insulin Resistance
por: Alghanim, Ghazi, et al.
Publicado: (2019)

Dermatoglyphic meta-analysis indicates early epigenetic outcomes & possible implications on genomic zygosity in type-2 diabetes
por: Yohannes, Seile
Publicado: (2015)

Insulin Resistance and Type 2 Diabetes
por: Taylor, Roy
Publicado: (2012)

NADPH Oxidases Connecting Fatty Liver Disease, Insulin Resistance and Type 2 Diabetes: Current Knowledge and Therapeutic Outlook
por: Nascè, Alberto, et al.
Publicado: (2022)

Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes
por: Zatterale, Federica, et al.
Publicado: (2020)

Hepatocyte TRAF3 promotes insulin resistance and type 2 diabetes in mice with obesity
por: Chen, Zheng, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_154n7kmcsu6f1ahn0bt4b228gn